EU says yes to Roche drug

EU approves a first in class therapy for treatment of patients with moderate to severe form of rheumatoid arthritis.

Oasmia gets a confirmation

FDA has granted Oasmia an expedited review status for Paclical Vet.

New NO product reduces diabetic pain

The Swedish medtech company Nolabs has announced that it has achieved an important milestone in the development of a new line of products.

Positive combined cancer therapy

Topotarget announces positive data with new treatment against colorectal cancer.

Woman deficit in Swedish research

The IP firm Awapatent will soon launch its Innovation Barometer 2009. This year Awapatent reveals that the statistics is even worse, compared to last year.

Measure blood sugar without finger pricking

The Danish entrepreneurial firm RSP Systems has developed a method to measure the blood sugar level in diabetes patients, simply by placing a fingertip on a small illuminating lens.

Pronova Biopharma grows

Recently, Norway's Pronova Biopharma announced the creation of new jobs in Denmark

Medicult disclaims Swedish offer

The Norwegian company Medicult's Board is highly sceptical to the yesterday announced Vitrolife offer.

LEO Pharma - International Clinical Trial Manager

Prenatal testing breakthrough

For the first time specific gene expression information from fetal cells isolated from maternal blood samples is available.

Danish discovery could help cardiac patients

The Danish researchers have developed a component that could make live easier forpatients with heart failure.

New faces in Pronova Biopharma team

The Norwegian company Pronova Biopharma has recently changed the management team structure.

Orion cuts 205 jobs

The Finnish company Orion has completed its statutory negotiations. By this, personnel will be reduced by about 205 in Finland.

Cancer cells cheat suicide call

Cancer cells cheat death by reversing a process which causes normal cells to commit suicide at the end of their natural life, researchers from the University of Hong Kong have shown.

Meda gets access to Asia

The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.

Academy for a new turn at work

Are you qualified within life science, but unemployed? Here is your chance for a new career, in high demand.

Bring talent to those in need

Ho ho ho, Christmas time is here again. So get busy decking the halls, perhaps not with assorted greenery, but with something of a more lasting value.

Ambassador program makes MVA big in Japan

The first ambassadors of the Medicon Valley Ambassador Programme have only worked in each other's countries for six months. But they have already made a significant difference for their sister clusters.

Martin Bergö: "The Idea is the Thing"

Martin Bergö, 38, goes wherever ideas take him - it's a process that has led to, and resulted from, plenty of unexpected results. Those ideas have been recognized as good ones: in 2008, he was awarded the Eric K. Fernström Foundation's Prize for young researchers. It isn't the first award for the Associate Professor at Gothenburg University's Sahlgrenska Academy. In 2007, he received a grant award of 16 million SEK from the European Research Council for his pioneering work.